ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 118,000
+100 (0.08%)
At close: Dec 5, 2025
ST Pharm Company Description
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate.
The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics.
It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
ST Pharm Co.,Ltd.
| Country | South Korea |
| Founded | 1983 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 655 |
| CEO | Mooje Sung |
Contact Details
Address: Sihwa Industrial Complex 1na 802 Siheung-si, 15086 South Korea | |
| Phone | 82 3 1488 1300 |
| Website | stpharm.co.kr |
Stock Details
| Ticker Symbol | 237690 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7237690003 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mooje Sung | Chief Executive Officer |
| YiHwan Kim | Chief Financial Officer |